Modified LeuCD Enzyme Complexes for Selective C7-C11 2-Ketoacid Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing C 6 -C 10 alcohols, C 5 -C 9 alkanes, and C 6 -C 10 carboxylic acids are inefficient and lack selectivity, with microbial organisms failing to produce these chemicals at economically viable rates, and existing petrochemical processes generate unwanted by-products and have narrow carbon chain length distributions.
Innovation Solution
Genetically modified LeuCD' enzyme complexes, comprising specific amino acid sequence modifications in the LeuC and LeuD subunits, are used to convert C 4 -C 10 2-ketoacids into C 7 -C 11 2-ketoacids through isopropylmalate isomerase activity, enabling the production of longer chain aldehydes, alcohols, and carboxylic acids.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If petrochemical processes (Ziegler process, SHOP) are used to produce C6-C10 alcohols, then production capacity is achieved, but selectivity to narrow carbon chain length distribution is poor and unwanted by-products are generated
Solution Approach 1:
The patent modifies the carbon chain length range targeted by the biochemical pathway (C4-C10 substrates to C7-C11 products) and optimizes enzyme complex parameters (amino acid substitutions in LeuC and LeuD subunits) to achieve narrow distribution selectivity while maintaining production capacity
Solution Approach 2:
The patent replaces petrochemical mechanical/chemical processes (ethylene oligomerization, hydroformylation) with a biochemical system using genetically modified enzyme complexes that naturally provide selectivity through substrate specificity and enzymatic reaction pathways
2Object-affected harmful factors
If microbial organisms are used to produce C6-C10 alcohols and C6-C10 carboxylic acids, then environmentally friendly production is achieved, but economically viable rates and yields are not attained
Solution Approach 1:
The patent enhances microbial productivity by modifying enzyme complex parameters through site-directed mutagenesis (amino acid substitutions) to improve catalytic efficiency, and by extending the carbon chain length range to access higher-value C7-C11 products with better economic viability
Solution Approach 2:
The patent uses E. coli as a model microbial system to replicate and optimize the leucine biosynthetic pathway, copying successful metabolic engineering strategies from amino acid production to chemical production while achieving economically viable rates
3Adaptability or versatility
If LeuABCD genes are engineered to extend 2-ketoacids inside cells, then range of biochemicals that can be produced is expanded, but major bottlenecks in later stages of the pathway remain
Solution Approach 1:
The patent modifies the substrate scope parameters of the LeuCD enzyme complex through amino acid substitutions, enabling it to accept longer chain 2-ketoacids (C6-C10) that the native enzyme cannot process, thereby removing the bottleneck in later pathway stages
Solution Approach 2:
The patent creates a dynamic enzyme system where the modified LeuCD' complex can adaptively process a broader range of substrate chain lengths, allowing the pathway to flexibly produce various C7-C11 biochemicals based on substrate availability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The modified LeuCD' enzyme complexes enhance the production of C 7 -C 11 2-ketoacids, allowing for the efficient synthesis of longer chain aldehydes, alcohols, and carboxylic acids, providing bio-based alternatives to fossil fuels.
Implementation Method 1
Genetically modified LeuCD' enzyme complexes, comprising specific amino acid sequence modifications in the LeuC and LeuD subunits, are used to convert C 4 -C 10 2-ketoacids into C 7 -C 11 2-ketoacids through isopropylmalate isomerase activity
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Genetically modified LeuCD' enzyme complexes, processes for preparing a C7-C11 2-ketoacid utilizing genetically modified LeuCD' enzyme complexes, and microbial organisms including modified LeuCD enzyme complexes are described. The instantly-disclosed genetically modified LeuCD' enzyme complexes, processes for preparing a C7-C11 2-ketoacid, and microbial organisms including modified LeuCD' enzyme complexes can be particularly useful for producing C6-C10 aldehydes, alkanes, alcohols, and carboxylic acids, both in vivo and in vitro.